306 related articles for article (PubMed ID: 15545082)
1. The design and exogenous delivery of siRNA for post-transcriptional gene silencing.
Gilmore IR; Fox SP; Hollins AJ; Sohail M; Akhtar S
J Drug Target; 2004 Jul; 12(6):315-40. PubMed ID: 15545082
[TBL] [Abstract][Full Text] [Related]
2. Delivery strategies for siRNA-mediated gene silencing.
Gilmore IR; Fox SP; Hollins AJ; Akhtar S
Curr Drug Deliv; 2006 Apr; 3(2):147-5. PubMed ID: 16611001
[TBL] [Abstract][Full Text] [Related]
3. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Akhtar S; Benter I
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
[TBL] [Abstract][Full Text] [Related]
4. Construction and Biological Evaluation of a Novel Integrin α
Chen X; Liu M; Wang R; Yan P; Zhang C; Ma C; Yin L
Molecules; 2017 Feb; 22(2):. PubMed ID: 28165399
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of short interfering RNAs--strategies for in vivo delivery.
Wullner U; Neef I; Tur MK; Barth S
Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):1-8. PubMed ID: 19149683
[TBL] [Abstract][Full Text] [Related]
6. Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics.
Gentile E; Oba T; Lin J; Shao R; Meng F; Cao X; Lin HY; Mourad M; Pataer A; Baladandayuthapani V; Cai D; Roth JA; Ji L
Oncotarget; 2017 Jul; 8(29):48222-48239. PubMed ID: 28637023
[TBL] [Abstract][Full Text] [Related]
7. Action and reaction: the biological response to siRNA and its delivery vehicles.
Kanasty RL; Whitehead KA; Vegas AJ; Anderson DG
Mol Ther; 2012 Mar; 20(3):513-24. PubMed ID: 22252451
[TBL] [Abstract][Full Text] [Related]
8. siRNAs: their potential as therapeutic agents--Part II. Methods of delivery.
Singh SK; Hajeri PB
Drug Discov Today; 2009 Sep; 14(17-18):859-65. PubMed ID: 19540929
[TBL] [Abstract][Full Text] [Related]
9. Oral delivery of siRNA and antisense oligonucleotides.
Akhtar S
J Drug Target; 2009 Aug; 17(7):491-5. PubMed ID: 19530907
[TBL] [Abstract][Full Text] [Related]
10. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.
De Paula D; Bentley MV; Mahato RI
RNA; 2007 Apr; 13(4):431-56. PubMed ID: 17329355
[TBL] [Abstract][Full Text] [Related]
12. [Research progress on the development of the strategies for siRNAs delivery in vivo].
Tang D; Mao A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
[TBL] [Abstract][Full Text] [Related]
13. Strategies for in vivo delivery of siRNAs: recent progress.
Higuchi Y; Kawakami S; Hashida M
BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
[TBL] [Abstract][Full Text] [Related]
14. TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.
Keates AC; Fruehauf J; Xiang S; Li CJ
Biotechnol Genet Eng Rev; 2008; 25():113-27. PubMed ID: 21412352
[TBL] [Abstract][Full Text] [Related]
15. Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.
De Backer L; Cerrada A; Pérez-Gil J; De Smedt SC; Raemdonck K
J Control Release; 2015 Dec; 220(Pt B):642-50. PubMed ID: 26363301
[TBL] [Abstract][Full Text] [Related]
16. Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics.
Akhtari J; Tafazoli A; Mehrad-Majd H; Mahrooz A
Curr Clin Pharmacol; 2018; 13(3):173-182. PubMed ID: 29992895
[TBL] [Abstract][Full Text] [Related]
17. Advances in siRNA delivery in cancer therapy.
Singh A; Trivedi P; Jain NK
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):274-283. PubMed ID: 28423924
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic face of RNAi: in vivo challenges.
Borna H; Imani S; Iman M; Azimzadeh Jamalkandi S
Expert Opin Biol Ther; 2015 Feb; 15(2):269-85. PubMed ID: 25399911
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of RNA interference against cancer.
Takeshita F; Ochiya T
Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
[TBL] [Abstract][Full Text] [Related]
20. Delivering siRNA with Dendrimers: In Vivo Applications.
Leiro V; Santos SD; Pego AP
Curr Gene Ther; 2017; 17(2):105-119. PubMed ID: 28494741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]